UBS Group’s Adial Pharmaceuticals, Inc Warrant ADILW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-6,534
| Closed | -$39 | – | 9002 |
|
|
2023
Q2 | $39 | Buy |
+6,534
| New | +$39 | ﹤0.01% | 7545 |
|
|
2021
Q4 | – | Sell |
-2
| Closed | – | – | 9635 |
|
|
2021
Q3 | $0 | Buy |
+2
| New | – | ﹤0.01% | 9027 |
|
|
2021
Q2 | – | Sell |
-4,961
| Closed | -$3K | – | 8758 |
|
|
2021
Q1 | $3K | Buy |
4,961
+1,242
| +33% | +$751 | ﹤0.01% | 7514 |
|
|
2020
Q4 | $1K | Sell |
3,719
-24
| -0.6% | -$6 | ﹤0.01% | 7248 |
|
|
2020
Q3 | $1K | Sell |
3,743
-4,973
| -57% | -$1.33K | ﹤0.01% | 6985 |
|
|
2020
Q2 | $2K | Sell |
8,716
-358
| -4% | -$82 | ﹤0.01% | 6826 |
|
|
2020
Q1 | $1K | Sell |
9,074
-428
| -5% | -$47 | ﹤0.01% | 6911 |
|
|
2019
Q4 | $2K | Hold |
9,502
| – | – | ﹤0.01% | 6798 |
|
|
2019
Q3 | $2K | Hold |
9,502
| – | – | ﹤0.01% | 6801 |
|
|
2019
Q2 | $2K | Buy |
9,502
+2,885
| +44% | +$607 | ﹤0.01% | 6775 |
|
|
2019
Q1 | $3K | Buy |
6,617
+2,536
| +62% | +$1.15K | ﹤0.01% | 6532 |
|
|
2018
Q4 | $2K | Buy |
4,081
+4,080
| +408,000% | +$2K | ﹤0.01% | 6895 |
|
|
2018
Q3 | $0 | Buy |
+1
| New | – | ﹤0.01% | 7240 |
|